期刊文献+

青心酮防治ApoE(-/-)小鼠主动脉粥样硬化斑块形成与脂氧素的关系 被引量:3

Relationship between 3,4-Dihydroxyaceto-phenone Prevention of Atherosclerosis and Lipoxin in ApoE(-/-) mice
原文传递
导出
摘要 目的观察青心酮防治ApoE(-/-)小鼠主动脉粥样硬化(AS)病变形成与脂氧素的关系。方法取8只8周龄C57BL/6小鼠作空白对照组;取24只8周龄的ApoE(-/-)小鼠,♂,随机分成3组(每组8只):动脉硬化组(乙醇20 mg kg 1 d 1);青心酮组(青心酮20 mg kg 1 d 1);辛伐他汀组(辛伐他汀20 mg kg 1 d 1)。所有小鼠均以"西方类型膳食"饲养至16周。取血检测脂氧素、血脂和15-脂氧合酶蛋白的含量等;取主动脉根部行HE染色观察ApoE(-/-)主动脉粥样硬化病变情况;电镜观察斑块内皮细胞变化。Western blotting法测定血清中15-LO水平。结果青心酮组脂氧素增加,血脂含量降低,AS病灶形成减少,斑块内皮细胞损伤减轻,15-脂氧合酶含量减少。结论青心酮防治ApoE(-/-)小鼠AS病变,可能与其增加15-脂氧合酶途径产物——脂氧素有关。 OBJECTIVE To observe the relationship between 3,4-Dihydroxyaceto-phenone(DHAP) prevention of atherosclerosis(AS) and lipoxins(LXs) in ApoE(-/-) mice. METHODS There were 8 eight-week-old C57BL/6 mice in the normal control group; 24 eight-week-old male ApoE (-/-) mice were randomly divided into three groups: AS group (n=8, ip. alcohol 20 mg.kg-1.d-1); DHAP treatment group (n=8, ip. DHAP 20 mg.kg-1.d-1); simvastatin treatment group (n=8, ip. simvastatin 20 mg.kg-1.d-1). All mice were fed with a Western diet (21% fat, 0.15% cholesterol) for 16 weeks. Their blood was collected for determination of blood lipids and lipoxin concentration. Sections of aortic root were stained by HE. The structures of cells were observed by electron microscope. Western-blotting was applied to detect 15-LO protein in serum. RESULTS The concentration of LXs increased in DHAP-treated group. The concentration of TG and TC decreased in DHAP-treated group; the formation of AS plaque was reduced; the injuries of cells decreased; 15-1ipoxygenase also increased at atherosclerosis plaque in DHAP-treated group. CONCLUSION It is suggested that DHAP could be used effectively for the prevention and treatment of AS, possibly through promoting the 15-1ipoxygenase product synthesis of anti-inflammatory lipoxin pathway.
出处 《中国现代应用药学》 CAS CSCD 2012年第3期195-198,共4页 Chinese Journal of Modern Applied Pharmacy
基金 山东省自然科学基金项目(ZR2009CQ013)
关键词 青心酮 脂氧素 15-脂氧合酶 动脉粥样硬化 3,4-dihydroxyacetophenone lipoxins 15-1ipoxygenase atherosclerosis
  • 相关文献

参考文献14

  • 1ZHANGL WANJY YEDY etal.Lipoxin and Inflammation subside.生命的化学,2004,24(1):61-63.
  • 2NAIKI Y,SORRENTINO R,WONG M H,et al.TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration ofatherosclerosis[J].Immunol,2008,181(10):7176-7185.
  • 3吴萍,黄引平,叶笃筠.青心酮活血化瘀作用机制的研究进展[J].中草药,2001,32(3):277-277. 被引量:22
  • 4ROSS R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 5CHARLES N,SERHAN,NAN CHIANG AND THOMAS E,et al.Resolving inflammation:dual anti-inflammatory and proresolution lipid mediators[J].Imunology,2008,8(5):349-361.
  • 6SERHAN C N.Guetsted.Special Issue on Lipoxins and Aspirin Triggered Lipoxins Prostaglandins Leukot[J].Essent Fatty Acids,2005,73(3-4):141-162.
  • 7CELIK G E,ERKEKOL F O,MISIRLIGIL Z,et al.Lipoxin A4level inastema:relation with disease severity and aspirin sensitivity[J].Clinical and Experimental Allergy,2007,37(10):1494-1501.
  • 8YACOUBIAN S,SERHAN C N.New endogenous anti-inflammatory and proresolving lipid mediators:implications for rheumatic diseases[J].Nat Clin Pract Rheumatol,2007,3(10):570-579.
  • 9HENNEKENS CH,SECHENOVA O,HOLLAR D,et al.Dose of aspirin in the treatment and prevention of cardiovascular disease:current and future directions[J].Cardiovasc Pharmacol Ther,2006,11(3):170-176.
  • 10FAROOQUI A A.Lipid mediators in the neural cell nucleus:their metabolism,signaling,and association with neurological disorders[J].Neuroscientist,2009,15(4):392-407.

二级参考文献18

共引文献25

同被引文献42

  • 1曹艳,许自川,何小解,党西强,易著文,曾雪琪.儿茶素拮抗过氧化氢诱导的大鼠内皮祖细胞凋亡[J].中国当代儿科杂志,2009,11(1):61-64. 被引量:13
  • 2张芙荣,陈君柱,朱军慧,王兴祥,朱建华,尚云鹏,郭晓纲,戴禾敏,孙坚.葛根素对外周血内皮祖细胞数量和功能的影响[J].中国中药杂志,2004,29(8):777-781. 被引量:42
  • 3匡荣,薛冬,康桦,倪维芳,姚治,郑筱祥.益心酮胶囊对大鼠高脂血症的影响[J].中国现代应用药学,2005,22(5):359-360. 被引量:3
  • 4张伟,李锋,王玉琴,王春华,沈燕.二苯乙烯苷对实验性动脉粥样硬化大鼠血脂和炎症因子的调节作用[J].中国临床药理学与治疗学,2007,12(5):516-520. 被引量:22
  • 5BROWN M S, GOLDSTEIN J L. Lipoprotein metabolism inthe macrophage: implications for cholesterol deposition inatherosclerosis [J]. Annu Rev Biochem, 1983, 52(1): 223-261.
  • 6SUN J F. Studies of protective effects and mechanisms of HLFon myocardial ischemia in dogs [D]. Jilin: Univ of Jilin, 2000.
  • 7SCHIEFFER B,SCHIEFFER E, HILFIKER-KLEINER D, etal. Expression of angiotensin II and interleukin-6 in humancoronary atheroscleroticplaques potential implications forinflammation and plaque instability [J]. Circulation, 2000,101(12): 1372-1378.
  • 8HAROKOPAKIS E, HAJISHENGALLIS G. Integrinactivation by bacterial fimbriae through a pathway involvingCD 14,Toll-like receptor-2, and phosphatidylinositol-3-kinase[J]. Eur J Immunol, 2005,35(4): 1201-1210.
  • 9Kim H A,Seo K H,Kang Y R,et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression [J].Cell Physiol Biochem,2011,27( 1):55-62.
  • 10Cubbon H M,Kahn M B,Wheatcroft S B.Effects of insulin re-sistance on endothelial progenitor cells and vascular repair [J].Clin Sci,2009,117(5) :173-190.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部